SCHEMBL7262260

SCHEMBL7262260

CCC(C=O)(C(=O)O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ CYP2C19 P33261 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ CYP1A2 P05177 3/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CYP2D6 P10635 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ KIF11 P52732 1/20 0.38
▸ KCNN4 O15554 3/20 0.38
▸ HDAC1 Q13547 2/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ OPRM1 P35372 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ CYP2C9 P11712 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CHRM2 P08172 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20556841 0.83 ALDH1A1 (0.49) ALDH1A1TSHRCYP2C19HIF1ACYP1A2
SCHEMBL27872022 0.83 ALDH1A1 (0.41) ALDH1A1TSHRCYP2C19HIF1ACYP1A2
SCHEMBL11327202 0.83 ALDH1A1 (0.49) ALDH1A1TSHRCYP2C19HIF1ACYP1A2
SCHEMBL29216345 0.82 ALDH1A1 (0.43) ALDH1A1TSHRCYP2C19HIF1ACYP1A2
SCHEMBL9199514 0.82 KCNN4 (0.53) ALDH1A1KMT2AMEN1MAPTKCNN4
SCHEMBL7261292 0.82 THRB (0.45) ALDH1A1MAPTLMNAL3MBTL1
SCHEMBL1970368 0.81 MAOB (0.47) ALDH1A1KMT2AMAPTHTT
SCHEMBL28302147 0.81 KCNN4 (0.40) TSHRCYP2C19HIF1ACYP1A2KMT2A
SCHEMBL8052831 0.78 KIF11 (0.40) ALDH1A1TSHRCYP1A2CYP2D6KIF11
SCHEMBL6671068 0.75 KMT2A (0.44) ALDH1A1KMT2AMEN1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106323969-A Content determination method of ethyl formylphenylacetate 江苏吉贝尔药业股份有限公司 2017-01-11 — — CN disclosed
US-6645983-B1 Heterocyclic imines such as 3-(4-methoxyphenyl)-1,4-dihydro-4 -quinolinone, used as anticarcinogenic agents having cytolysis efficiency; side effect reduction LABORATOIRE L. LAFON (FR) 2003-11-11 — — US disclosed
US-4089858-A Heterocyclic-amino-acrylic acid derivatives CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1978-05-16 — — US disclosed
Send feedback